{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:42:08Z","timestamp":1794328928018,"version":"4.9.0"},"reference-count":204,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"crossref","award":["NHRI-EX111-11136NI"],"award-info":[{"award-number":["NHRI-EX111-11136NI"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 109-2320-B-002-073 \u2013"],"award-info":[{"award-number":["MOST 109-2320-B-002-073 \u2013"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006477","name":"National Taiwan University","doi-asserted-by":"crossref","award":["NTU-110-A-CC-5400-64841"],"award-info":[{"award-number":["NTU-110-A-CC-5400-64841"]}],"id":[{"id":"10.13039\/501100006477","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parkinson\u2019s disease (PD) is the second most common neurodegenerative disease attributed to the synergistic effects of genetic risk and environmental stimuli. Although PD is characterized by motor dysfunction resulting from intraneuronal alpha-synuclein accumulations, termed Lewy bodies, and dopaminergic neuronal degeneration in the substantia nigra, multiple systems are involved in the disease process, resulting in heterogenous clinical presentation and progression. Genetic predisposition to PD regarding aberrant immune responses, abnormal protein aggregation, autophagolysosomal impairment, and mitochondrial dysfunction leads to vulnerable neurons that are sensitive to environmental triggers and, together, result in neuronal degeneration. Neuropathology studies have shown that, at least in some patients, Lewy bodies start from the enteric nervous system and then spread to the central dopaminergic neurons through the gut\u2013brain axis, suggesting the contribution of an altered gut microenvironment in the pathogenesis of PD. A plethora of evidence has revealed different gut microbiomes and gut metabolites in patients with PD compared to unaffected controls. Chronic gut inflammation and impaired intestinal barrier integrity have been observed in human PD patients and mouse models of PD. These observations led to the hypothesis that an altered gut microenvironment is a potential trigger of the PD process in a genetically susceptible host. In this review, we will discuss the complex interplay between genetic factors and gut microenvironmental changes contributing to PD pathogenesis.<\/jats:p>","DOI":"10.1186\/s12929-022-00839-6","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T14:33:26Z","timestamp":1659105206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Gut microenvironmental changes as a potential trigger in Parkinson\u2019s disease through the gut\u2013brain axis"],"prefix":"10.1186","volume":"29","author":[{"given":"Szu-Ju","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8566-7573","authenticated-orcid":false,"given":"Chin-Hsien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"key":"839_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Breteler MM. Epidemiology of Parkinson\u2019s disease. Lancet Neurol. 2006;5:525\u201335.","journal-title":"Lancet Neurol"},{"key":"839_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"Collaborators GBDPsD","year":"2018","unstructured":"Collaborators GBDPsD. Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:939\u201353.","journal-title":"Lancet Neurol"},{"key":"839_CR3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386:896\u2013912.","journal-title":"Lancet"},{"key":"839_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/mds.25664","volume":"29","author":"GW Duncan","year":"2014","unstructured":"Duncan GW, Khoo TK, Yarnall AJ, O\u2019Brien JT, Coleman SY, Brooks DJ, Barker RA, Burn DJ. Health-related quality of life in early Parkinson\u2019s disease: the impact of nonmotor symptoms. Mov Disord. 2014;29:195\u2013202.","journal-title":"Mov Disord"},{"key":"839_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert M, Spillantini MG, Del Tredici K, Braak H. 100 years of Lewy pathology. Nat Rev Neurol. 2013;9:13\u201324.","journal-title":"Nat Rev Neurol"},{"key":"839_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jnnp-2015-311680","volume":"87","author":"KL Adams-Carr","year":"2016","unstructured":"Adams-Carr KL, Bestwick JP, Shribman S, Lees A, Schrag A, Noyce AJ. Constipation preceding Parkinson\u2019s disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2016;87:710\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"839_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes CH, Del Tredici K, Braak H. Parkinson\u2019s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol. 2007;33:599\u2013614.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"839_CR8","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/brain\/awaa096","volume":"143","author":"ML Arotcarena","year":"2020","unstructured":"Arotcarena ML, Dovero S, Prigent A, Bourdenx M, Camus S, Porras G, Thiolat ML, Tasselli M, Aubert P, Kruse N, et al. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates. Brain. 2020;143:1462\u201375.","journal-title":"Brain"},{"key":"839_CR9","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, et al. Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron. 2019;103:627-641.e627.","journal-title":"Neuron"},{"key":"839_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","volume":"23","author":"C Challis","year":"2020","unstructured":"Challis C, Hori A, Sampson TR, Yoo BB, Challis RC, Hamilton AM, Mazmanian SK, Volpicelli-Daley LA, Gradinaru V. Gut-seeded alpha-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat Neurosci. 2020;23:327\u201336.","journal-title":"Nat Neurosci"},{"key":"839_CR11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.nbd.2018.01.008","volume":"112","author":"FP Manfredsson","year":"2018","unstructured":"Manfredsson FP, Luk KC, Benskey MJ, Gezer A, Garcia J, Kuhn NC, Sandoval IM, Patterson JR, O\u2019Mara A, Yonkers R, Kordower JH. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology. Neurobiol Dis. 2018;112:106\u201318.","journal-title":"Neurobiol Dis"},{"key":"839_CR12","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, Zhang B, O\u2019Brien P, Trojanowski JQ, Lee VM. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012;338:949\u201353.","journal-title":"Science"},{"issue":"3","key":"839_CR13","first-page":"83","volume":"30","author":"YT Chu","year":"2021","unstructured":"Chu YT, Tai CH, Lin CH, Wu RM. Updates on the genetics of Parkinson\u2019s disease: clinical implications and future treatment. Acta Neurol Taiwan. 2021;30(3):83\u201393.","journal-title":"Acta Neurol Taiwan"},{"key":"839_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41531-020-0110-8","volume":"6","author":"J Tran","year":"2020","unstructured":"Tran J, Anastacio H, Bardy C. Genetic predispositions of Parkinson\u2019s disease revealed in patient-derived brain cells. NPJ Parkinson\u2019s Dis. 2020;6:8.","journal-title":"NPJ Parkinson's Dis"},{"key":"839_CR15","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/mds.27059","volume":"32","author":"AJ Lee","year":"2017","unstructured":"Lee AJ, Wang Y, Alcalay RN, Mejia-Santana H, Saunders-Pullman R, Bressman S, Corvol JC, Brice A, Lesage S, Mangone G, et al. Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry. Mov Disord. 2017;32:1432\u20138.","journal-title":"Mov Disord"},{"key":"839_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","volume":"8","author":"KR Chaudhuri","year":"2009","unstructured":"Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009;8:464\u201374.","journal-title":"Lancet Neurol"},{"key":"839_CR17","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, et al. MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord. 2015;30:1600\u201311.","journal-title":"Mov Disord"},{"key":"839_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41531-022-00295-x","volume":"8","author":"T Warnecke","year":"2022","unstructured":"Warnecke T, Sch\u00e4fer KH, Claus I, Del Tredici K, Jost WH. Gastrointestinal involvement in Parkinson\u2019s disease: pathophysiology, diagnosis, and management. NPJ Parkinsons Dis. 2022;8:31.","journal-title":"NPJ Parkinsons Dis"},{"key":"839_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1212\/WNL.57.3.456","volume":"57","author":"RD Abbott","year":"2001","unstructured":"Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW. Frequency of bowel movements and the future risk of Parkinson\u2019s disease. Neurology. 2001;57:456\u201362.","journal-title":"Neurology"},{"key":"839_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1474-4422(14)70287-X","volume":"14","author":"A Schrag","year":"2015","unstructured":"Schrag A, Horsfall L, Walters K, Noyce A, Petersen I. Prediagnostic presentations of Parkinson\u2019s disease in primary care: a case-control study. Lancet Neurol. 2015;14:57\u201364.","journal-title":"Lancet Neurol"},{"key":"839_CR21","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ana.23687","volume":"72","author":"AJ Noyce","year":"2012","unstructured":"Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, Lees AJ, Schrag A. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012;72:893\u2013901.","journal-title":"Ann Neurol"},{"key":"839_CR22","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.parkreldis.2014.09.026","volume":"20","author":"CH Lin","year":"2014","unstructured":"Lin CH, Lin JW, Liu YC, Chang CH, Wu RM. Risk of Parkinson\u2019s disease following severe constipation: a nationwide population-based cohort study. Parkinsonism Relat Disord. 2014;20:1371\u20135.","journal-title":"Parkinsonism Relat Disord"},{"key":"839_CR23","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","volume":"73","author":"R Savica","year":"2009","unstructured":"Savica R, Carlin JM, Grossardt BR, Bower JH, Ahlskog JE, Maraganore DM, Bharucha AE, Rocca WA. Medical records documentation of constipation preceding Parkinson disease: a case-control study. Neurology. 2009;73:1752\u20138.","journal-title":"Neurology"},{"key":"839_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/mds.26866","volume":"32","author":"K Knudsen","year":"2017","unstructured":"Knudsen K, Krogh K, \u00d8stergaard K, Borghammer P. Constipation in Parkinson\u2019s disease: subjective symptoms, objective markers, and new perspectives. Mov Disord. 2017;32:94\u2013105.","journal-title":"Mov Disord"},{"key":"839_CR25","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1007\/s00415-019-09321-0","volume":"267","author":"M Rolli-Derkinderen","year":"2019","unstructured":"Rolli-Derkinderen M, Leclair-Visonneau L, Bourreille A, Coron E, Neunlist M, Derkinderen P. Is Parkinson\u2019s disease a chronic low-grade inflammatory bowel disease? J Neurol. 2019;267:2207\u201313.","journal-title":"J Neurol"},{"key":"839_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/mds.27326","volume":"33","author":"MC Houser","year":"2018","unstructured":"Houser MC, Chang J, Factor SA, Molho ES, Zabetian CP, Hill-Burns EM, Payami H, Hertzberg VS, Tansey MG. Stool immune profiles evince gastrointestinal inflammation in Parkinson\u2019s disease. Mov Disord. 2018;33:793\u2013804.","journal-title":"Mov Disord"},{"key":"839_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.parkreldis.2018.02.022","volume":"50","author":"A Schwiertz","year":"2018","unstructured":"Schwiertz A, Spiegel J, Dillmann U, Grundmann D, B\u00fcrmann J, Fa\u00dfbender K, Sch\u00e4fer K-H, Unger MM. Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2018;50:104\u20137.","journal-title":"Parkinsonism Relat Disord"},{"key":"839_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","volume":"50","author":"D Devos","year":"2013","unstructured":"Devos D, Lebouvier T, Lardeux B, Biraud M, Rouaud T, Pouclet H, Coron E, Bruley des Varannes S, Naveilhan P, Nguyen J-M, et al. Colonic inflammation in Parkinson\u2019s disease. Neurobiol Dis. 2013;50:42\u20138.","journal-title":"Neurobiol Dis"},{"key":"839_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/gutjnl-2017-315666","volume":"68","author":"M Villumsen","year":"2019","unstructured":"Villumsen M, Aznar S, Pakkenberg B, Jess T, Brudek T. Inflammatory bowel disease increases the risk of Parkinson\u2019s disease: a Danish nationwide cohort study 1977\u20132014. Gut. 2019;68:18\u201324.","journal-title":"Gut"},{"key":"839_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.dld.2018.09.017","volume":"51","author":"F Zhu","year":"2019","unstructured":"Zhu F, Li C, Gong J, Zhu W, Gu L, Li N. The risk of Parkinson\u2019s disease in inflammatory bowel disease: a systematic review and meta-analysis. Dig Liver Dis. 2019;51:38\u201342.","journal-title":"Dig Liver Dis"},{"key":"839_CR31","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/jamaneurol.2018.0605","volume":"75","author":"I Peter","year":"2018","unstructured":"Peter I, Dubinsky M, Bressman S, Park A, Lu C, Chen N, Wang A. Anti-tumor necrosis factor therapy and incidence of Parkinson disease among patients with inflammatory bowel disease. JAMA Neurol. 2018;75:939\u201346.","journal-title":"JAMA Neurol"},{"key":"839_CR32","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T, Wang ZY, Roybon L, Melki R, Li JY. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014;128:805\u201320.","journal-title":"Acta Neuropathol"},{"key":"839_CR33","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2018.06.021","volume":"174","author":"A Zeisel","year":"2018","unstructured":"Zeisel A, Hochgerner H, Lonnerberg P, Johnsson A, Memic F, van der Zwan J, Haring M, Braun E, Borm LE, La Manno G, et al. Molecular architecture of the mouse nervous system. Cell. 2018;174:999-1014.e1022.","journal-title":"Cell"},{"key":"839_CR34","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1172\/JCI81121","volume":"125","author":"DV Bohorquez","year":"2015","unstructured":"Bohorquez DV, Liddle RA. The gut connectome: making sense of what you eat. J Clin Invest. 2015;125:888\u201390.","journal-title":"J Clin Invest"},{"key":"839_CR35","first-page":"203","volume":"28","author":"M Carabotti","year":"2015","unstructured":"Carabotti M, Scirocco A, Maselli MA, Severi C. The gut\u2013brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015;28:203\u20139.","journal-title":"Ann Gastroenterol"},{"key":"839_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","volume":"396","author":"H Braak","year":"2006","unstructured":"Braak H, de Vos RA, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology. Neurosci Lett. 2006;396:67\u201372.","journal-title":"Neurosci Lett"},{"key":"839_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-013-1214-6","volume":"127","author":"D Hilton","year":"2014","unstructured":"Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J, Broughton E, Hagan H, Carroll C. Accumulation of \u03b1-synuclein in the bowel of patients in the pre-clinical phase of Parkinson\u2019s disease. Acta Neuropathol. 2014;127:235\u201341.","journal-title":"Acta Neuropathol"},{"key":"839_CR38","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mds.25020","volume":"27","author":"KM Shannon","year":"2012","unstructured":"Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH. Is alpha-synuclein in the colon a biomarker for premotor Parkinson\u2019s disease? Evidence from 3 cases. Mov Disord. 2012;27:716\u20139.","journal-title":"Mov Disord"},{"key":"839_CR39","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ana.24648","volume":"79","author":"MG Stokholm","year":"2016","unstructured":"Stokholm MG, Danielsen EH, Hamilton-Dutoit SJ, Borghammer P. Pathological \u03b1-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients. Ann Neurol. 2016;79:940\u20139.","journal-title":"Ann Neurol"},{"key":"839_CR40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2990.2007.00923.x","volume":"34","author":"ME Kalaitzakis","year":"2008","unstructured":"Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson\u2019s disease: a critical analysis of alpha-synuclein staging. Neuropathol Appl Neurobiol. 2008;34:284\u201395.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"839_CR41","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Bj\u00f6rklund A, et al. Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat Med. 2008;14:501\u20133.","journal-title":"Nat Med"},{"key":"839_CR42","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat Med. 2008;14:504\u20136.","journal-title":"Nat Med"},{"key":"839_CR43","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/mds.23012","volume":"25","author":"JY Li","year":"2010","unstructured":"Li JY, Englund E, Widner H, Rehncrona S, Bj\u00f6rklund A, Lindvall O, Brundin P. Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson\u2019s disease. Mov Disord. 2010;25:1091\u20136.","journal-title":"Mov Disord"},{"key":"839_CR44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.celrep.2017.12.009","volume":"22","author":"YR Choi","year":"2018","unstructured":"Choi YR, Cha S-H, Kang S-J, Kim J-B, Jou I, Park SM. Prion-like propagation of a-synuclein is regulated by the Fc\u03b3RIIB-SHP-1\/2 signaling pathway in neurons. Cell Rep. 2018;22:136\u201348.","journal-title":"Cell Rep"},{"key":"839_CR45","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, Zhang B, O\u2019Brien P, Trojanowski JQ, Lee VM. Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012;338:949\u201353.","journal-title":"Science"},{"key":"839_CR46","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, et al. Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron. 2019;103:627-641.e627.","journal-title":"Neuron"},{"key":"839_CR47","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","volume":"138","author":"N Van Den Berge","year":"2019","unstructured":"Van Den Berge N, Ferreira N, Gram H, Mikkelsen TW, Alstrup AKO, Casadei N, Tsung-Pin P, Riess O, Nyengaard JR, Tamg\u00fcney G, et al. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Acta Neuropathol. 2019;138:535\u201350.","journal-title":"Acta Neuropathol"},{"key":"839_CR48","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/srep00898","volume":"2","author":"F Pan-Montojo","year":"2012","unstructured":"Pan-Montojo F, Schwarz M, Winkler C, Arnhold M, O\u2019Sullivan GA, Pal A, Said J, Marsico G, Verbavatz J-M, Rodrigo-Angulo M, et al. Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep. 2012;2:898.","journal-title":"Sci Rep"},{"key":"839_CR49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41531-018-0066-0","volume":"4","author":"L Anselmi","year":"2018","unstructured":"Anselmi L, Bove C, Coleman FH, Le K, Subramanian MP, Venkiteswaran K, Subramanian T, Travagli RA. Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat. NPJ Parkinson\u2019s Dis. 2018;4:30\u201330.","journal-title":"NPJ Parkinson's Dis"},{"key":"839_CR50","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24448","volume":"78","author":"E Svensson","year":"2015","unstructured":"Svensson E, Horv\u00e1th-Puh\u00f3 E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, S\u00f8rensen HT. Vagotomy and subsequent risk of Parkinson\u2019s disease. Ann Neurol. 2015;78:522\u20139.","journal-title":"Ann Neurol"},{"key":"839_CR51","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","volume":"88","author":"B Liu","year":"2017","unstructured":"Liu B, Fang F, Pedersen NL, Tillander A, Ludvigsson JF, Ekbom A, Svenningsson P, Chen H, Wirdefeldt K. Vagotomy and Parkinson disease: a Swedish register-based matched-cohort study. Neurology. 2017;88:1996\u20132002.","journal-title":"Neurology"},{"key":"839_CR52","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","volume":"62","author":"Y-T Sui","year":"2014","unstructured":"Sui Y-T, Bullock KM, Erickson MA, Zhang J, Banks WA. Alpha synuclein is transported into and out of the brain by the blood-brain barrier. Peptides. 2014;62:197\u2013202.","journal-title":"Peptides"},{"key":"839_CR53","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/srep02540","volume":"3","author":"PG Foulds","year":"2013","unstructured":"Foulds PG, Diggle P, Mitchell JD, Parker A, Hasegawa M, Masuda-Suzukake M, Mann DM, Allsop D. A longitudinal study on \u03b1-synuclein in blood plasma as a biomarker for Parkinson\u2019s disease. Sci Rep. 2013;3:2540.","journal-title":"Sci Rep"},{"key":"839_CR54","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3389\/fneur.2019.01388","volume":"10","author":"C-W Chang","year":"2020","unstructured":"Chang C-W, Yang S-Y, Yang C-C, Chang C-W, Wu Y-R. Plasma and serum Alpha-synuclein as a biomarker of diagnosis in patients with Parkinson\u2019s disease. Front Neurol. 2020;10:1388. https:\/\/doi.org\/10.3389\/fneur.2019.01388.","journal-title":"Front Neurol"},{"key":"839_CR55","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/mds.25779","volume":"29","author":"MT Gray","year":"2014","unstructured":"Gray MT, Munoz DG, Gray DA, Schlossmacher MG, Woulfe JM. Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects. Mov Disord. 2014;29:991\u20138.","journal-title":"Mov Disord"},{"key":"839_CR56","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/mds.26473","volume":"31","author":"SJ Chung","year":"2016","unstructured":"Chung SJ, Kim J, Lee HJ, Ryu H-S, Kim K, Lee JH, Jung KW, Kim MJ, Kim M-J, Kim YJ, et al. Alpha-synuclein in gastric and colonic mucosa in Parkinson\u2019s disease: limited role as a biomarker. Mov Disord. 2016;31:241\u20139.","journal-title":"Mov Disord"},{"key":"839_CR57","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/mds.26670","volume":"31","author":"C Marras","year":"2016","unstructured":"Marras C, Lang AE, Austin PC, Lau C, Urbach DR. Appendectomy in mid and later life and risk of Parkinson\u2019s disease: a population-based study. Mov Disord. 2016;31:1243\u20137.","journal-title":"Mov Disord"},{"key":"839_CR58","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1002\/mds.26761","volume":"31","author":"E Svensson","year":"2016","unstructured":"Svensson E, Horv\u00e1th-Puh\u00f3 E, Stokholm MG, S\u00f8rensen HT, Henderson VW, Borghammer P. Appendectomy and risk of Parkinson\u2019s disease: a nationwide cohort study with more than 10 years of follow-up. Mov Disord. 2016;31:1918\u201322.","journal-title":"Mov Disord"},{"key":"839_CR59","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/mds.109","volume":"33","author":"N Palacios","year":"2018","unstructured":"Palacios N, Hughes KC, Cereda E, Schwarzschild MA, Ascherio A. Appendectomy and risk of Parkinson\u2019s disease in two large prospective cohorts of men and women. Mov Disord. 2018;33:1492\u20136.","journal-title":"Mov Disord"},{"key":"839_CR60","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/mds.26311","volume":"30","author":"A Mendes","year":"2015","unstructured":"Mendes A, Gon\u00e7alves A, Vila-Ch\u00e3 N, Moreira I, Fernandes J, Dam\u00e1sio J, Teixeira-Pinto A, Taipa R, Lima AB, Cavaco S. Appendectomy may delay Parkinson\u2019s disease Onset. Mov Disord. 2015;30:1404\u20137.","journal-title":"Mov Disord"},{"key":"839_CR61","doi-asserted-by":"publisher","first-page":"eaar5280","DOI":"10.1126\/scitranslmed.aar5280","volume":"10","author":"BA Killinger","year":"2018","unstructured":"Killinger BA, Madaj Z, Sikora JW, Rey N, Haas AJ, Vepa Y, Lindqvist D, Chen H, Thomas PM, Brundin P, et al. The vermiform appendix impacts the risk of developing Parkinson\u2019s disease. Sci Transl Med. 2018;10:eaar5280.","journal-title":"Sci Transl Med"},{"key":"839_CR62","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000477990","volume":"9","author":"E Stolzenberg","year":"2017","unstructured":"Stolzenberg E, Berry D, Yang D, Lee EY, Kroemer A, Kaufman S, Wong GCL, Oppenheim JJ, Sen S, Fishbein T, et al. A role for neuronal alpha-synuclein in gastrointestinal immunity. J Innate Immun. 2017;9:456\u201363.","journal-title":"J Innate Immun"},{"key":"839_CR63","doi-asserted-by":"publisher","first-page":"110090","DOI":"10.1016\/j.celrep.2021.110090","volume":"38","author":"MM Alam","year":"2022","unstructured":"Alam MM, Yang D, Li XQ, Liu J, Back TC, Trivett A, Karim B, Barbut D, Zasloff M, Oppenheim JJ. Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function. Cell Rep. 2022;38:110090.","journal-title":"Cell Rep"},{"key":"839_CR64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41531-021-00263-x","volume":"8","author":"C Pellegrini","year":"2022","unstructured":"Pellegrini C, D\u2019Antongiovanni V, Miraglia F, Rota L, Benvenuti L, Di Salvo C, Testa G, Capsoni S, Carta G, Antonioli L, et al. Enteric alpha-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson\u2019s disease before brain pathology. NPJ Parkinsons Dis. 2022;8:9.","journal-title":"NPJ Parkinsons Dis"},{"key":"839_CR65","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1002\/mds.28594","volume":"36","author":"X Kang","year":"2021","unstructured":"Kang X, Ploner A, Roelstraete B, Khalili H, Williams DM, Pedersen NL, Ludvigsson JF, Wirdefeldt K. Association between microscopic colitis and Parkinson\u2019s disease in a Swedish population. Mov Disord. 2021;36:1919\u201326.","journal-title":"Mov Disord"},{"key":"839_CR66","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gutjnl-2018-316844","volume":"68","author":"P Perez-Pardo","year":"2019","unstructured":"Perez-Pardo P, Dodiya HB, Engen PA, Forsyth CB, Huschens AM, Shaikh M, Voigt RM, Naqib A, Green SJ, Kordower JH, et al. Role of TLR4 in the gut-brain axis in Parkinson\u2019s disease: a translational study from men to mice. Gut. 2019;68:829\u201343.","journal-title":"Gut"},{"key":"839_CR67","doi-asserted-by":"publisher","first-page":"689723","DOI":"10.3389\/fnins.2021.689723","volume":"15","author":"L Dumitrescu","year":"2021","unstructured":"Dumitrescu L, Marta D, D\u0103n\u0103u A, Lefter A, Tulb\u0103 D, Cozma L, Manole E, Gherghiceanu M, Ceafalan LC, Popescu BO. Serum and fecal markers of intestinal inflammation and intestinal barrier permeability are elevated in Parkinson\u2019s disease. Front Neurosci. 2021;15:689723.","journal-title":"Front Neurosci"},{"key":"839_CR68","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/MIB.0000000000000735","volume":"22","author":"JC Lin","year":"2016","unstructured":"Lin JC, Lin CS, Hsu CW, Lin CL, Kao CH. Association between Parkinson\u2019s disease and inflammatory bowel disease: a Nationwide Taiwanese Retrospective Cohort Study. Inflamm Bowel Dis. 2016;22:1049\u201355.","journal-title":"Inflamm Bowel Dis"},{"key":"839_CR69","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/ibd\/izy190","volume":"25","author":"P Weimers","year":"2019","unstructured":"Weimers P, Halfvarson J, Sachs MC, Saunders-Pullman R, Ludvigsson JF, Peter I, Burisch J, Ol\u00e9n O. Inflammatory bowel disease and Parkinson\u2019s disease: a nationwide Swedish cohort study. Inflamm Bowel Dis. 2019;25:111\u201323.","journal-title":"Inflamm Bowel Dis"},{"key":"839_CR70","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3390\/jcm8081191","volume":"8","author":"S Park","year":"2019","unstructured":"Park S, Kim J, Chun J, Han K, Soh H, Kang EA, Lee HJ, Im JP, Kim JS. Patients with inflammatory bowel disease are at an increased risk of Parkinson\u2019s disease: a South Korean nationwide population-based study. J Clin Med. 2019;8:1191.","journal-title":"J Clin Med"},{"key":"839_CR71","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4103\/1673-5374.317981","volume":"17","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Yuan M, Liu Y, Yang F, Chen W-Z, Xu Z-Z, Xiang Z-B, Xu R-S. Association between inflammatory bowel diseases and Parkinson\u2019s disease: systematic review and meta-analysis. Neural Regen Res. 2022;17:344\u201353.","journal-title":"Neural Regen Res"},{"key":"839_CR72","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","volume":"74","author":"A Witoelar","year":"2017","unstructured":"Witoelar A, Jansen IE, Wang Y, Desikan RS, Gibbs JR, Blauwendraat C, Thompson WK, Hernandez DG, Djurovic S, Schork AJ, et al. Genome-wide pleiotropy between Parkinson disease and autoimmune diseases. JAMA Neurol. 2017;74:780\u201392.","journal-title":"JAMA Neurol"},{"key":"839_CR73","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA, Noyce AJ, Xue A, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18:1091\u2013102.","journal-title":"Lancet Neurol"},{"key":"839_CR74","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1111\/j.1471-4159.2010.06879.x","volume":"114","author":"RF Villar\u00e1n","year":"2010","unstructured":"Villar\u00e1n RF, Espinosa-Oliva AM, Sarmiento M, De Pablos RM, Arg\u00fcelles S, Delgado-Cort\u00e9s MJ, Sobrino V, Van Rooijen N, Venero JL, Herrera AJ, et al. Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease. J Neurochem. 2010;114:1687\u2013700.","journal-title":"J Neurochem"},{"key":"839_CR75","doi-asserted-by":"publisher","first-page":"7297","DOI":"10.1007\/s12035-018-0937-8","volume":"55","author":"P Garrido-Gil","year":"2018","unstructured":"Garrido-Gil P, Rodriguez-Perez AI, Dominguez-Meijide A, Guerra MJ, Labandeira-Garcia JL. Bidirectional neural interaction between central dopaminergic and gut lesions in Parkinson\u2019s disease models. Mol Neurobiol. 2018;55:7297\u2013316.","journal-title":"Mol Neurobiol"},{"key":"839_CR76","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/mds.28890","volume":"37","author":"C-H Lin","year":"2022","unstructured":"Lin C-H, Lin H-Y, Ho E-P, Ke Y-C, Cheng M-F, Shiue C-Y, Wu C-H, Liao P-H, Hsu AY-H, Chu L-A, et al. Mild chronic colitis triggers parkinsonism in LRRK2 mutant mice through activating TNF-\u03b1 pathway. Mov Disord. 2022;37:745\u201357.","journal-title":"Mov Disord"},{"key":"839_CR77","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12017-019-08539-5","volume":"21","author":"Y Kishimoto","year":"2019","unstructured":"Kishimoto Y, Zhu W, Hosoda W, Sen JM, Mattson MP. Chronic mild gut inflammation accelerates brain neuropathology and motor dysfunction in \u03b1-synuclein mutant mice. Neuromol Med. 2019;21:239\u201349.","journal-title":"Neuromol Med"},{"key":"839_CR78","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s40478-021-01240-4","volume":"9","author":"MC Houser","year":"2021","unstructured":"Houser MC, Caudle WM, Chang J, Kannarkat GT, Yang Y, Kelly SD, Oliver D, Joers V, Shannon KM, Keshavarzian A, Tansey MG. Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology. Acta Neuropathol Commun. 2021;9:139.","journal-title":"Acta Neuropathol Commun"},{"key":"839_CR79","doi-asserted-by":"publisher","first-page":"845930","DOI":"10.3389\/fphar.2022.845930","volume":"13","author":"LY Chung","year":"2022","unstructured":"Chung LY, Lin YT, Liu C, Tai YC, Lin HY, Lin CH, Chen CC. Neuroinflammation upregulated neuronal toll-like receptors 2 and 4 to drive synucleinopathy in neurodegeneration. Front Pharmacol. 2022;13:845930.","journal-title":"Front Pharmacol"},{"key":"839_CR80","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00401-018-1943-7","volume":"137","author":"A Prigent","year":"2019","unstructured":"Prigent A, Lionnet A, Durieu E, Chapelet G, Bourreille A, Neunlist M, Rolli-Derkinderen M, Derkinderen P. Enteric alpha-synuclein expression is increased in Crohn\u2019s disease. Acta Neuropathol. 2019;137:359\u201361.","journal-title":"Acta Neuropathol"},{"key":"839_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","volume":"50","author":"C Chelakkot","year":"2018","unstructured":"Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med. 2018;50:1\u20139.","journal-title":"Exp Mol Med"},{"key":"839_CR82","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/mi.2016.75","volume":"10","author":"MY Zeng","year":"2017","unstructured":"Zeng MY, Inohara N, Nu\u00f1ez G. Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol. 2017;10:18\u201326.","journal-title":"Mucosal Immunol"},{"key":"839_CR83","doi-asserted-by":"publisher","first-page":"102863","DOI":"10.1016\/j.isci.2021.102863","volume":"24","author":"HJ Rosenberg","year":"2021","unstructured":"Rosenberg HJ, Rao M. Enteric glia in homeostasis and disease: from fundamental biology to human pathology. iScience. 2021;24:102863.","journal-title":"iScience"},{"key":"839_CR84","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","volume":"68","author":"M Camilleri","year":"2019","unstructured":"Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019;68:1516.","journal-title":"Gut"},{"key":"839_CR85","doi-asserted-by":"publisher","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, Estes JD, Dodiya HB, Keshavarzian A. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS ONE. 2011;6:e28032.","journal-title":"PLoS ONE"},{"key":"839_CR86","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-015-0196-0","volume":"3","author":"T Clairembault","year":"2015","unstructured":"Clairembault T, Leclair-Visonneau L, Coron E, Bourreille A, Le Dily S, Vavasseur F, Heymann MF, Neunlist M, Derkinderen P. Structural alterations of the intestinal epithelial barrier in Parkinson\u2019s disease. Acta Neuropathol Commun. 2015;3:12.","journal-title":"Acta Neuropathol Commun"},{"key":"839_CR87","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-021-00427-6","volume":"16","author":"VTE Aho","year":"2021","unstructured":"Aho VTE, Houser MC, Pereira PAB, Chang J, Rudi K, Paulin L, Hertzberg V, Auvinen P, Tansey MG, Scheperjans F. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease. Mol Neurodegener. 2021;16:6.","journal-title":"Mol Neurodegener"},{"key":"839_CR88","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/mds.25736","volume":"29","author":"LP Kelly","year":"2014","unstructured":"Kelly LP, Carvey PM, Keshavarzian A, Shannon KM, Shaikh M, Bakay RAE, Kordower JH. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson\u2019s disease. Mov Disord. 2014;29:999\u20131009.","journal-title":"Mov Disord"},{"key":"839_CR89","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41531-021-00263-x","volume":"8","author":"C Pellegrini","year":"2022","unstructured":"Pellegrini C, D\u2019Antongiovanni V, Miraglia F, Rota L, Benvenuti L, Di Salvo C, Testa G, Capsoni S, Carta G, Antonioli L, et al. Enteric \u03b1-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson\u2019s disease before brain pathology. NPJ Parkinson\u2019s Dis. 2022;8:9.","journal-title":"NPJ Parkinson's Dis"},{"key":"839_CR90","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.3233\/JPD-212574","volume":"11","author":"SJ Chen","year":"2021","unstructured":"Chen SJ, Chi YC, Ho CH, Yang WS, Lin CH. Plasma lipopolysaccharide-binding protein reflects risk and progression of Parkinson\u2019s disease. J Parkinsons Dis. 2021;11:1129\u201339.","journal-title":"J Parkinsons Dis"},{"key":"839_CR91","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1212\/WNL.0000000000013225","volume":"98","author":"SJ Chen","year":"2022","unstructured":"Chen SJ, Chen CC, Liao HY, Lin YT, Wu YW, Liou JM, Wu MS, Kuo CH, Lin CH. Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease. Neurology. 2022;98:e848\u201358.","journal-title":"Neurology"},{"key":"839_CR92","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29063","author":"X Yang","year":"2022","unstructured":"Yang X, Ai P, He X, Mo C, Zhang Y, Xu S, Lai Y, Qian Y, Xiao Q. Parkinson\u2019s disease is associated with impaired gut-blood barrier for short-chain fatty acids. Mov Disord. 2022. https:\/\/doi.org\/10.1002\/mds.29063.","journal-title":"Mov Disord"},{"key":"839_CR93","doi-asserted-by":"publisher","first-page":"16003","DOI":"10.1038\/npjbiofilms.2016.3","volume":"2","author":"SP Claus","year":"2016","unstructured":"Claus SP, Guillou H, Ellero-Simatos S. The gut microbiota: a major player in the toxicity of environmental pollutants? NPJ Biofilms Microbiomes. 2016;2:16003.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"839_CR94","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","volume":"19","author":"LH Morais","year":"2021","unstructured":"Morais LH, Schreiber HL, Mazmanian SK. The gut microbiota\u2013brain axis in behaviour and brain disorders. Nat Rev Microbiol. 2021;19:241\u201355.","journal-title":"Nat Rev Microbiol"},{"key":"839_CR95","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3233\/JPD-202237","volume":"11","author":"MS Cirstea","year":"2021","unstructured":"Cirstea MS, Sundvick K, Golz E, Yu AC, Boutin RCT, Kliger D, Finlay BB, Appel-Cresswell S. The gut mycobiome in Parkinson\u2019s disease. J Parkinsons Dis. 2021;11:153\u20138.","journal-title":"J Parkinsons Dis"},{"key":"839_CR96","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","volume":"9","author":"JR Bedarf","year":"2017","unstructured":"Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, Bork P, W\u00fcllner U. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients. Genome Med. 2017;9:39.","journal-title":"Genome Med"},{"key":"839_CR97","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.parkreldis.2022.01.005","volume":"95","author":"E De Pablo-Fernandez","year":"2022","unstructured":"De Pablo-Fernandez E, Gebeyehu GG, Flain L, Slater R, Frau A, Ijaz UZ, Warner T, Probert C. The faecal metabolome and mycobiome in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2022;95:65\u20139.","journal-title":"Parkinsonism Relat Disord"},{"key":"839_CR98","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13099-021-00420-w","volume":"13","author":"X Li","year":"2021","unstructured":"Li X, Feng X, Jiang Z, Jiang Z. Association of small intestinal bacterial overgrowth with Parkinson\u2019s disease: a systematic review and meta-analysis. Gut Pathog. 2021;13:25.","journal-title":"Gut Pathog"},{"key":"839_CR99","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.parkreldis.2014.02.019","volume":"20","author":"AH Tan","year":"2014","unstructured":"Tan AH, Mahadeva S, Thalha AM, Gibson PR, Kiew CK, Yeat CM, Ng SW, Ang SP, Chow SK, Tan CT, et al. Small intestinal bacterial overgrowth in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2014;20:535\u201340.","journal-title":"Parkinsonism Relat Disord"},{"key":"839_CR100","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/mds.25522","volume":"28","author":"A Fasano","year":"2013","unstructured":"Fasano A, Bove F, Gabrielli M, Petracca M, Zocco MA, Ragazzoni E, Barbaro F, Piano C, Fortuna S, Tortora A, et al. The role of small intestinal bacterial overgrowth in Parkinson\u2019s disease. Mov Disord. 2013;28:1241\u20139.","journal-title":"Mov Disord"},{"key":"839_CR101","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/mds.28119","volume":"35","author":"H Nishiwaki","year":"2020","unstructured":"Nishiwaki H, Ito M, Ishida T, Hamaguchi T, Maeda T, Kashihara K, Tsuboi Y, Ueyama J, Shimamura T, Mori H, et al. Meta-analysis of gut dysbiosis in Parkinson\u2019s disease. Mov Disord. 2020;35:1626\u201335.","journal-title":"Mov Disord"},{"key":"839_CR102","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A. Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinson\u2019s Dis. 2021;7:27.","journal-title":"NPJ Parkinson's Dis"},{"key":"839_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2021.11.017","volume":"94","author":"TS Toh","year":"2022","unstructured":"Toh TS, Chong CW, Lim SY, Bowman J, Cirstea M, Lin CH, Chen CC, Appel-Cresswell S, Finlay BB, Tan AH. Gut microbiome in Parkinson\u2019s disease: new insights from meta-analysis. Parkinsonism Relat Disord. 2022;94:1\u20139.","journal-title":"Parkinsonism Relat Disord"},{"key":"839_CR104","doi-asserted-by":"publisher","first-page":"636545","DOI":"10.3389\/fnagi.2021.636545","volume":"13","author":"T Shen","year":"2021","unstructured":"Shen T, Yue Y, He T, Huang C, Qu B, Lv W, Lai HY. The association between the gut microbiota and Parkinson\u2019s disease, a meta-analysis. Front Aging Neurosci. 2021;13:636545.","journal-title":"Front Aging Neurosci"},{"key":"839_CR105","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-019-1528-y","volume":"16","author":"CH Lin","year":"2019","unstructured":"Lin CH, Chen CC, Chiang HL, Liou JM, Chang CM, Lu TP, Chuang EY, Tai YC, Cheng C, Lin HY, Wu MS. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease. J Neuroinflamm. 2019;16:129.","journal-title":"J Neuroinflamm"},{"key":"839_CR106","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-020-0112-6","volume":"6","author":"ZD Wallen","year":"2020","unstructured":"Wallen ZD, Appah M, Dean MN, Sesler CL, Factor SA, Molho E, Zabetian CP, Standaert DG, Payami H. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. NPJ Parkinsons Dis. 2020;6:11.","journal-title":"NPJ Parkinsons Dis"},{"key":"839_CR107","doi-asserted-by":"publisher","first-page":"652617","DOI":"10.3389\/fcimb.2021.652617","volume":"11","author":"KE Murros","year":"2021","unstructured":"Murros KE, Huynh VA, Takala TM, Saris PEJ. Desulfovibrio bacteria are associated with Parkinson\u2019s disease. Front Cell Infect Microbiol. 2021;11:652617.","journal-title":"Front Cell Infect Microbiol"},{"key":"839_CR108","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1093\/brain\/awaa201","volume":"143","author":"Y Qian","year":"2020","unstructured":"Qian Y, Yang X, Xu S, Huang P, Li B, Du J, He Y, Su B, Xu LM, Wang L, et al. Gut metagenomics-derived genes as potential biomarkers of Parkinson\u2019s disease. Brain. 2020;143:2474\u201389.","journal-title":"Brain"},{"key":"839_CR109","doi-asserted-by":"publisher","first-page":"108807","DOI":"10.1016\/j.celrep.2021.108807","volume":"34","author":"D Rosario","year":"2021","unstructured":"Rosario D, Bidkhori G, Lee S, Bedarf J, Hildebrand F, Le Chatelier E, Uhlen M, Ehrlich SD, Proctor G, W\u00fcllner U, et al. Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson\u2019s disease. Cell Rep. 2021;34:108807.","journal-title":"Cell Rep"},{"key":"839_CR110","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","volume":"10","author":"SP van Kessel","year":"2019","unstructured":"van Kessel SP, Frye AK, El-Gendy AO, Castejon M, Keshavarzian A, van Dijk G, El Aidy S. Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson\u2019s disease. Nat Commun. 2019;10:310.","journal-title":"Nat Commun"},{"key":"839_CR111","doi-asserted-by":"publisher","first-page":"eaau6323","DOI":"10.1126\/science.aau6323","volume":"364","author":"V Maini Rekdal","year":"2019","unstructured":"Maini Rekdal V, Bess EN, Bisanz JE, Turnbaugh PJ, Balskus EP. Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science. 2019;364:eaau6323.","journal-title":"Science"},{"key":"839_CR112","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fneur.2020.00137","volume":"11","author":"T Ren","year":"2020","unstructured":"Ren T, Gao Y, Qiu Y, Jiang S, Zhang Q, Zhang J, Wang L, Zhang Y, Wang L, Nie K. Gut microbiota altered in mild cognitive impairment compared with normal cognition in sporadic Parkinson\u2019s disease. Front Neurol. 2020;11:137.","journal-title":"Front Neurol"},{"key":"839_CR113","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell. 2016;167:1469-1480.e1412.","journal-title":"Cell"},{"key":"839_CR114","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3233\/JPD-202297","volume":"11","author":"R Cilia","year":"2021","unstructured":"Cilia R, Piatti M, Cereda E, Bolliri C, Caronni S, Ferri V, Cassani E, Bonvegna S, Ferrarese C, Zecchinelli AL, et al. Does gut microbiota influence the course of Parkinson\u2019s Disease? a 3-year prospective exploratory study in de novo patients. J Parkinsons Dis. 2021;11:159\u201370.","journal-title":"J Parkinsons Dis"},{"key":"839_CR115","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, De la Fuente MK, Landskron G, Gonz\u00e1lez MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:277.","journal-title":"Front Immunol"},{"key":"839_CR116","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41531-019-0100-x","volume":"5","author":"S Weis","year":"2019","unstructured":"Weis S, Schwiertz A, Unger MM, Becker A, Fa\u00dfbender K, Ratering S, Kohl M, Schnell S, Sch\u00e4fer KH, Egert M. Effect of Parkinson\u2019s disease and related medications on the composition of the fecal bacterial microbiota. NPJ Parkinsons Dis. 2019;5:28.","journal-title":"NPJ Parkinsons Dis"},{"key":"839_CR117","first-page":"117","volume":"57","author":"E Cassani","year":"2011","unstructured":"Cassani E, Privitera G, Pezzoli G, Pusani C, Madio C, Iorio L, Barichella M. Use of probiotics for the treatment of constipation in Parkinson\u2019s disease patients. Minerva Gastroenterol Dietol. 2011;57:117\u201321.","journal-title":"Minerva Gastroenterol Dietol"},{"key":"839_CR118","doi-asserted-by":"publisher","first-page":"103908","DOI":"10.1016\/j.isci.2022.103908","volume":"25","author":"DP Amorim Neto","year":"2022","unstructured":"Amorim Neto DP, Bosque BP, Pereira de Godoy JV, Rodrigues PV, Meneses DD, Tostes K, Costa Tonoli CC, Faustino de Carvalho H, Gonz\u00e1lez-Billault C, de Castro Fonseca M. Akkermansia muciniphila induces mitochondrial calcium overload and \u03b1 -synuclein aggregation in an enteroendocrine cell line. iScience. 2022;25:103908.","journal-title":"iScience"},{"key":"839_CR119","doi-asserted-by":"publisher","first-page":"e92295","DOI":"10.1172\/jci.insight.92295","volume":"2","author":"R Chandra","year":"2017","unstructured":"Chandra R, Hiniker A, Kuo YM, Nussbaum RL, Liddle RA. alpha-Synuclein in gut endocrine cells and its implications for Parkinson\u2019s disease. JCI Insight. 2017;2:e92295.","journal-title":"JCI Insight"},{"key":"839_CR120","doi-asserted-by":"publisher","first-page":"e2106504118","DOI":"10.1073\/pnas.2106504118","volume":"118","author":"C Wang","year":"2021","unstructured":"Wang C, Lau CY, Ma F, Zheng C. Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration. Proc Natl Acad Sci USA. 2021;118:e2106504118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"839_CR121","doi-asserted-by":"publisher","first-page":"34477","DOI":"10.1038\/srep34477","volume":"6","author":"SG Chen","year":"2016","unstructured":"Chen SG, Stribinskis V, Rane MJ, Demuth DR, Gozal E, Roberts AM, Jagadapillai R, Liu R, Choe K, Shivakumar B, et al. Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged fischer 344 rats and Caenorhabditis elegans. Sci Rep. 2016;6:34477.","journal-title":"Sci Rep"},{"key":"839_CR122","doi-asserted-by":"publisher","first-page":"e53111","DOI":"10.7554\/eLife.53111","volume":"9","author":"TR Sampson","year":"2020","unstructured":"Sampson TR, Challis C, Jain N, Moiseyenko A, Ladinsky MS, Shastri GG, Thron T, Needham BD, Horvath I, Debelius JW, et al. A gut bacterial amyloid promotes \u03b1-synuclein aggregation and motor impairment in mice. Elife. 2020;9:e53111.","journal-title":"Elife"},{"key":"839_CR123","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3389\/fnins.2020.00716","volume":"14","author":"D Rosario","year":"2020","unstructured":"Rosario D, Boren J, Uhlen M, Proctor G, Aarsland D, Mardinoglu A, Shoaie S. Systems biology approaches to understand the host-microbiome interactions in neurodegenerative diseases. Front Neurosci. 2020;14:716.","journal-title":"Front Neurosci"},{"key":"839_CR124","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/mds.28052","volume":"35","author":"MS Cirstea","year":"2020","unstructured":"Cirstea MS, Yu AC, Golz E, Sundvick K, Kliger D, Radisavljevic N, Foulger LH, Mackenzie M, Huan T, Finlay BB, Appel-Cresswell S. Microbiota composition and metabolism are associated with gut function in Parkinson\u2019s disease. Mov Disord. 2020;35:1208\u201317.","journal-title":"Mov Disord"},{"key":"839_CR125","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.25982","volume":"89","author":"AH Tan","year":"2021","unstructured":"Tan AH, Chong CW, Lim SY, Yap IKS, Teh CSJ, Loke MF, Song SL, Tan JY, Ang BH, Tan YQ, et al. Gut microbial ecosystem in Parkinson disease: new clinicobiological insights from multi-omics. Ann Neurol. 2021;89:546\u201359.","journal-title":"Ann Neurol"},{"key":"839_CR126","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, Shannon KM. Colonic bacterial composition in Parkinson\u2019s disease. Mov Disord. 2015;30:1351\u201360.","journal-title":"Mov Disord"},{"key":"839_CR127","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nri.2017.25","volume":"17","author":"KJ Kieser","year":"2017","unstructured":"Kieser KJ, Kagan JC. Multi-receptor detection of individual bacterial products by the innate immune system. Nat Rev Immunol. 2017;17:376\u201390.","journal-title":"Nat Rev Immunol"},{"key":"839_CR128","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.4049\/jimmunol.1402598","volume":"195","author":"S Guo","year":"2015","unstructured":"Guo S, Nighot M, Al-Sadi R, Alhmoud T, Nighot P, Ma TY. Lipopolysaccharide regulation of intestinal tight junction permeability is mediated by TLR4 signal transduction pathway activation of FAK and MyD88. J Immunol. 2015;195:4999.","journal-title":"J Immunol"},{"key":"839_CR129","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1021\/acschemneuro.8b00733","volume":"10","author":"D Bhattacharyya","year":"2019","unstructured":"Bhattacharyya D, Mohite GM, Krishnamoorthy J, Gayen N, Mehra S, Navalkar A, Kotler SA, Ratha BN, Ghosh A, Kumar R, et al. Lipopolysaccharide from gut microbiota modulates \u03b1-synuclein aggregation and alters its biological function. ACS Chem Neurosci. 2019;10:2229\u201336.","journal-title":"ACS Chem Neurosci"},{"key":"839_CR130","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/glia.20467","volume":"55","author":"L Qin","year":"2007","unstructured":"Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong J-S, Knapp DJ, Crews FT. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55:453\u201362.","journal-title":"Glia"},{"key":"839_CR131","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/ibd.21402","volume":"17","author":"PL Lakatos","year":"2011","unstructured":"Lakatos PL, Kiss LS, Palatka K, Altorjay I, Antal-Szalmas P, Palyu E, Udvardy M, Molnar T, Farkas K, Veres G, et al. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn\u2019s disease. Inflamm Bowel Dis. 2011;17:767\u201377.","journal-title":"Inflamm Bowel Dis"},{"key":"839_CR132","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, Burmann J, Fassbender K, Schwiertz A, Schafer KH. Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat Disord. 2016;32:66\u201372.","journal-title":"Parkinsonism Relat Disord"},{"key":"839_CR133","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","volume":"17","author":"A Lavelle","year":"2020","unstructured":"Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020;17:223\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"839_CR134","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/mds.28016","volume":"35","author":"C Shin","year":"2020","unstructured":"Shin C, Lim Y, Lim H, Ahn T-B. Plasma short-chain fatty acids in patients with Parkinson\u2019s disease. Mov Disord. 2020;35:1021\u20137.","journal-title":"Mov Disord"},{"key":"839_CR135","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s10072-019-04143-4","volume":"41","author":"S Kumari","year":"2020","unstructured":"Kumari S, Goyal V, Kumaran SS, Dwivedi SN, Srivastava A, Jagannathan NR. Quantitative metabolomics of saliva using proton NMR spectroscopy in patients with Parkinson\u2019s disease and healthy controls. Neurol Sci. 2020;41:1201\u201310.","journal-title":"Neurol Sci"},{"key":"839_CR136","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cca.2020.08.005","volume":"510","author":"S Kumari","year":"2020","unstructured":"Kumari S, Kumaran SS, Goyal V, Sharma RK, Sinha N, Dwivedi SN, Srivastava AK, Jagannathan NR. Identification of potential urine biomarkers in idiopathic Parkinson\u2019s disease using NMR. Clin Chim Acta. 2020;510:442\u20139.","journal-title":"Clin Chim Acta"},{"key":"839_CR137","first-page":"302","volume":"10","author":"C-H Kim","year":"2022","unstructured":"Kim C-H, Jung J, Lee Y-U, Kim K-H, Kang S, Kang G-H, Chu H, Kim S-Y, Lee S. Comparison of metabolites and gut microbes between patients with Parkinson\u2019s disease and healthy individuals-a pilot clinical observational study (STROBE Compliant). Healthcare (Basel, Switzerland). 2022;10:302.","journal-title":"Healthcare (Basel, Switzerland)"},{"key":"839_CR138","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12883-021-02544-7","volume":"22","author":"G Wu","year":"2022","unstructured":"Wu G, Jiang Z, Pu Y, Chen S, Wang T, Wang Y, Xu X, Wang S, Jin M, Yao Y, et al. Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson\u2019s disease patients. BMC Neurol. 2022;22:13.","journal-title":"BMC Neurol"},{"key":"839_CR139","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1007\/s11064-020-03074-3","volume":"45","author":"C-M Qiao","year":"2020","unstructured":"Qiao C-M, Sun M-F, Jia X-B, Li Y, Zhang B-P, Zhao L-P, Shi Y, Zhou Z-L, Zhu Y-L, Cui C, Shen Y-Q. Sodium butyrate exacerbates Parkinson\u2019s disease by aggravating neuroinflammation and colonic inflammation in MPTP-induced mice model. Neurochem Res. 2020;45:2128\u201342.","journal-title":"Neurochem Res"},{"key":"839_CR140","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/hmg\/ddx114","volume":"26","author":"I Paiva","year":"2017","unstructured":"Paiva I, Pinho R, Pavlou MA, Hennion M, Wales P, Schutz AL, Rajput A, Szego EM, Kerimoglu C, Gerhardt E, et al. Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage. Hum Mol Genet. 2017;26:2231\u201346.","journal-title":"Hum Mol Genet"},{"key":"839_CR141","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jns.2017.08.3235","volume":"381","author":"J Liu","year":"2017","unstructured":"Liu J, Wang F, Liu S, Du J, Hu X, Xiong J, Fang R, Chen W, Sun J. Sodium butyrate exerts protective effect against Parkinson\u2019s disease in mice via stimulation of glucagon like peptide-1. J Neurol Sci. 2017;381:176\u201381.","journal-title":"J Neurol Sci"},{"key":"839_CR142","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.3390\/molecules25112502","volume":"25","author":"F Ostendorf","year":"2020","unstructured":"Ostendorf F, Metzdorf J, Gold R, Haghikia A, T\u00f6nges L. Propionic acid and fasudil as treatment against rotenone toxicity in an in vitro model of Parkinson\u2019s disease. Molecules. 2020;25:2502.","journal-title":"Molecules"},{"key":"839_CR143","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1423-0127-16-63","volume":"16","author":"SS Ahmed","year":"2009","unstructured":"Ahmed SS, Santosh W, Kumar S, Christlet HT. Metabolic profiling of Parkinson\u2019s disease: evidence of biomarker from gene expression analysis and rapid neural network detection. J Biomed Sci. 2009;16:63.","journal-title":"J Biomed Sci"},{"key":"839_CR144","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","volume":"9","author":"HM Roager","year":"2018","unstructured":"Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun. 2018;9:3294.","journal-title":"Nat Commun"},{"key":"839_CR145","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/jnnp-2014-309676","volume":"87","author":"T Hatano","year":"2016","unstructured":"Hatano T, Saiki S, Okuzumi A, Mohney RP, Hattori N. Identification of novel biomarkers for Parkinson\u2019s disease by metabolomic technologies. J Neurol Neurosurg Psychiatry. 2016;87:295\u2013301.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"839_CR146","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3233\/JPD-223179","volume":"12","author":"SJ Chen","year":"2022","unstructured":"Chen SJ, Chen CC, Liao HY, Wu YW, Liou JM, Wu MS, Kuo CH, Lin CH. Alteration of gut microbial metabolites in the systemic circulation of patients with Parkinson\u2019s disease. J Parkinsons Dis. 2022;12:1219\u201330.","journal-title":"J Parkinsons Dis"},{"key":"839_CR147","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.parkreldis.2015.02.004","volume":"21","author":"E Cassani","year":"2015","unstructured":"Cassani E, Barichella M, Cancello R, Cavanna F, Iorio L, Cereda E, Bolliri C, Zampella Maria P, Bianchi F, Cestaro B, Pezzoli G. Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2015;21:389\u201393.","journal-title":"Parkinsonism Relat Disord"},{"key":"839_CR148","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13024-018-0304-2","volume":"14","author":"Y Shao","year":"2019","unstructured":"Shao Y, Le W. Recent advances and perspectives of metabolomics-based investigations in Parkinson\u2019s disease. Mol Neurodegener. 2019;14:3.","journal-title":"Mol Neurodegener"},{"key":"839_CR149","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1021\/pr500807t","volume":"14","author":"H Luan","year":"2015","unstructured":"Luan H, Liu LF, Meng N, Tang Z, Chua KK, Chen LL, Song JX, Mok VC, Xie LX, Li M, Cai Z. LC-MS-based urinary metabolite signatures in idiopathic Parkinson\u2019s disease. J Proteome Res. 2015;14:467\u201378.","journal-title":"J Proteome Res"},{"key":"839_CR150","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/biom9060232","volume":"9","author":"Y Kiriyama","year":"2019","unstructured":"Kiriyama Y, Nochi H. The biosynthesis, signaling, and neurological functions of bile acids. Biomolecules. 2019;9:232.","journal-title":"Biomolecules"},{"key":"839_CR151","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/metabo11010029","volume":"11","author":"P Li","year":"2021","unstructured":"Li P, Killinger BA, Ensink E, Beddows I, Yilmaz A, Lubben N, Lamp J, Schilthuis M, Vega IE, Woltjer R, et al. Gut microbiota dysbiosis is associated with elevated bile acids in Parkinson\u2019s disease. Metabolites. 2021;11:29.","journal-title":"Metabolites"},{"key":"839_CR152","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13024-021-00425-8","volume":"16","author":"Y Shao","year":"2021","unstructured":"Shao Y, Li T, Liu Z, Wang X, Xu X, Li S, Xu G, Le W. Comprehensive metabolic profiling of Parkinson\u2019s disease by liquid chromatography-mass spectrometry. Mol Neurodegener. 2021;16:4.","journal-title":"Mol Neurodegener"},{"key":"839_CR153","doi-asserted-by":"publisher","first-page":"16690","DOI":"10.18632\/aging.103992","volume":"12","author":"SMS Yakhine-Diop","year":"2020","unstructured":"Yakhine-Diop SMS, Morales-Garc\u00eda JA, Niso-Santano M, Gonz\u00e1lez-Polo RA, Uribe-Carretero E, Martinez-Chacon G, Durand S, Maiuri MC, Aiastui A, Zulaica M, et al. Metabolic alterations in plasma from patients with familial and idiopathic Parkinson\u2019s disease. Aging. 2020;12:16690\u2013708.","journal-title":"Aging"},{"key":"839_CR154","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.3390\/cells9112394","volume":"9","author":"A Yilmaz","year":"2020","unstructured":"Yilmaz A, Ugur Z, Ustun I, Akyol S, Bahado-Singh RO, Maddens M, Aasly JO, Graham SF. Metabolic profiling of CSF from people suffering from sporadic and LRRK2 Parkinson\u2019s disease: a pilot study. Cells. 2020;9:2394.","journal-title":"Cells"},{"key":"839_CR155","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jalz.2018.07.217","volume":"15","author":"S MahmoudianDehkordi","year":"2019","unstructured":"MahmoudianDehkordi S, Arnold M, Nho K, Ahmad S, Jia W, Xie G, Louie G, Kueider-Paisley A, Moseley MA, Thompson JW, et al. Altered bile acid profile associates with cognitive impairment in Alzheimer\u2019s disease\u2014an emerging role for gut microbiome. Alzheimers Dement. 2019;15:76\u201392.","journal-title":"Alzheimers Dement"},{"key":"839_CR156","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41385-019-0162-4","volume":"12","author":"ML Chen","year":"2019","unstructured":"Chen ML, Takeda K, Sundrud MS. Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunol. 2019;12:851\u201361.","journal-title":"Mucosal Immunol"},{"key":"839_CR157","doi-asserted-by":"publisher","first-page":"e0208752","DOI":"10.1371\/journal.pone.0208752","volume":"13","author":"D Willkommen","year":"2018","unstructured":"Willkommen D, Lucio M, Moritz F, Forcisi S, Kanawati B, Smirnov KS, Schroeter M, Sigaroudi A, Schmitt-Kopplin P, Michalke B. Metabolomic investigations in cerebrospinal fluid of Parkinson\u2019s disease. PLoS ONE. 2018;13:e0208752.","journal-title":"PLoS ONE"},{"key":"839_CR158","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/mds.28246","volume":"35","author":"S-J Chen","year":"2020","unstructured":"Chen S-J, Kuo C-H, Kuo H-C, Chen C-C, Wu W-K, Liou J-M, Wu M-S, Lin C-H. The gut metabolite trimethylamine n-oxide is associated with Parkinson\u2019s disease severity and progression. Mov Disord. 2020;35:2115\u20136.","journal-title":"Mov Disord"},{"key":"839_CR159","doi-asserted-by":"publisher","first-page":"111090","DOI":"10.1016\/j.nut.2020.111090","volume":"83","author":"SJ Chung","year":"2021","unstructured":"Chung SJ, Rim JH, Ji D, Lee S, Yoo HS, Jung JH, Baik K, Choi Y, Ye BS, Sohn YH, et al. Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson\u2019s disease. Nutrition. 2021;83:111090.","journal-title":"Nutrition"},{"key":"839_CR160","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cca.2019.10.038","volume":"501","author":"B Sankowski","year":"2020","unstructured":"Sankowski B, Ksi\u0119\u017carczyk K, Ra\u0107kowska E, Szlufik S, Koziorowski D, Giebu\u0142towicz J. Higher cerebrospinal fluid to plasma ratio of p-cresol sulfate and indoxyl sulfate in patients with Parkinson\u2019s disease. Clin Chim Acta. 2020;501:165\u201373.","journal-title":"Clin Chim Acta"},{"key":"839_CR161","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1039\/C5MB00711A","volume":"12","author":"A Wuolikainen","year":"2016","unstructured":"Wuolikainen A, Jonsson P, Ahnlund M, Antti H, Marklund SL, Moritz T, Forsgren L, Andersen PM, Trupp M. Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson\u2019s disease and control subjects. Mol BioSyst. 2016;12:1287\u201398.","journal-title":"Mol BioSyst"},{"key":"839_CR162","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1021\/acscentsci.8b00879","volume":"5","author":"DK Trivedi","year":"2019","unstructured":"Trivedi DK, Sinclair E, Xu Y, Sarkar D, Walton-Doyle C, Liscio C, Banks P, Milne J, Silverdale M, Kunath T, et al. Discovery of volatile biomarkers of Parkinson\u2019s disease from sebum. ACS Cent Sci. 2019;5:599\u2013606.","journal-title":"ACS Cent Sci"},{"key":"839_CR163","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1212\/WNL.0000000000003663","volume":"88","author":"PA LeWitt","year":"2017","unstructured":"LeWitt PA, Li J, Lu M, Guo L, Auinger P. Metabolomic biomarkers as strong correlates of Parkinson disease progression. Neurology. 2017;88:862\u20139.","journal-title":"Neurology"},{"key":"839_CR164","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/acn3.724","volume":"6","author":"A Okuzumi","year":"2019","unstructured":"Okuzumi A, Hatano T, Ueno S-I, Ogawa T, Saiki S, Mori A, Koinuma T, Oji Y, Ishikawa K-I, Fujimaki M, et al. Metabolomics-based identification of metabolic alterations in PARK2. Ann Clin Transl Neurol. 2019;6:525\u201336.","journal-title":"Ann Clin Transl Neurol"},{"key":"839_CR165","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/mds.26992","volume":"32","author":"F Burt\u00e9","year":"2017","unstructured":"Burt\u00e9 F, Houghton D, Lowes H, Pyle A, Nesbitt S, Yarnall A, Yu-Wai-Man P, Burn DJ, Santibanez-Koref M, Hudson G. Metabolic profiling of Parkinson\u2019s disease and mild cognitive impairment. Mov Disord. 2017;32:927\u201332.","journal-title":"Mov Disord"},{"key":"839_CR166","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3233\/JAD-200306","volume":"78","author":"M Marizzoni","year":"2020","unstructured":"Marizzoni M, Cattaneo A, Mirabelli P, Festari C, Lopizzo N, Nicolosi V, Mombelli E, Mazzelli M, Luongo D, Naviglio D, et al. Short-chain fatty acids and lipopolysaccharide as mediators between gut dysbiosis and amyloid pathology in Alzheimer\u2019s disease. J Alzheimers Dis. 2020;78:683\u201397.","journal-title":"J Alzheimers Dis"},{"key":"839_CR167","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3390\/nu9101053","volume":"9","author":"D Del Rio","year":"2017","unstructured":"Del Rio D, Zimetti F, Caffarra P, Tassotti M, Bernini F, Brighenti F, Zini A, Zanotti I. The gut microbial metabolite trimethylamine-N-oxide is present in human cerebrospinal fluid. Nutrients. 2017;9:1053.","journal-title":"Nutrients"},{"key":"839_CR168","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat C, Nalls MA, Singleton AB. The genetic architecture of Parkinson\u2019s disease. Lancet Neurol. 2020;19:170\u20138.","journal-title":"Lancet Neurol"},{"key":"839_CR169","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/jnen\/nlx092","volume":"76","author":"N Naudet","year":"2017","unstructured":"Naudet N, Antier E, Gaillard D, Morignat E, Lakhdar L, Baron T, Bencsik A. Oral exposure to paraquat triggers earlier expression of phosphorylated \u03b1-synuclein in the enteric nervous system of A53T mutant human \u03b1-synuclein transgenic mice. J Neuropathol Exp Neurol. 2017;76:1046\u201357.","journal-title":"J Neuropathol Exp Neurol"},{"key":"839_CR170","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/nan.12644","volume":"47","author":"P La Vitola","year":"2021","unstructured":"La Vitola P, Balducci C, Baroni M, Artioli L, Santamaria G, Castiglioni M, Cerovic M, Colombo L, Caldinelli L, Pollegioni L, Forloni G. Peripheral inflammation exacerbates \u03b1-synuclein toxicity and neuropathology in Parkinson\u2019s models. Neuropathol Appl Neurobiol. 2021;47:43\u201360.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"839_CR171","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/brain\/awy077","volume":"141","author":"E Kozina","year":"2018","unstructured":"Kozina E, Sadasivan S, Jiao Y, Dou Y, Ma Z, Tan H, Kodali K, Shaw T, Peng J, Smeyne RJ. Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo. Brain. 2018;141:1753\u201369.","journal-title":"Brain"},{"key":"839_CR172","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.nbd.2015.12.020","volume":"91","author":"G Martella","year":"2016","unstructured":"Martella G, Madeo G, Maltese M, Vanni V, Puglisi F, Ferraro E, Schirinzi T, Valente EM, Bonanni L, Shen J, et al. Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice. Neurobiol Dis. 2016;91:21\u201336.","journal-title":"Neurobiol Dis"},{"key":"839_CR173","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-019-1405-y","volume":"571","author":"D Matheoud","year":"2019","unstructured":"Matheoud D, Cannon T, Voisin A, Penttinen A-M, Ramet L, Fahmy AM, Ducrot C, Laplante A, Bourque M-J, Zhu L, et al. Intestinal infection triggers Parkinson\u2019s disease-like symptoms in Pink1\u2212\/\u2212 mice. Nature. 2019;571:565\u20139.","journal-title":"Nature"},{"key":"839_CR174","doi-asserted-by":"publisher","first-page":"603849","DOI":"10.3389\/fnagi.2020.603849","volume":"12","author":"AM Gorecki","year":"2020","unstructured":"Gorecki AM, Bakeberg MC, Theunissen F, Kenna JE, Hoes ME, Pfaff AL, Akkari PA, Dunlop SA, K\u00f5ks S, Mastaglia FL, Anderton RS. Single nucleotide polymorphisms associated with gut homeostasis influence risk and age-at-onset of Parkinson\u2019s disease. Front Aging Neurosci. 2020;12:603849.","journal-title":"Front Aging Neurosci"},{"key":"839_CR175","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322429","author":"HS Lee","year":"2020","unstructured":"Lee HS, Lobbestael E, Vermeire S, Sabino J, Cleynen I. Inflammatory bowel disease and Parkinson\u2019s disease: common pathophysiological links. Gut. 2020. https:\/\/doi.org\/10.1136\/gutjnl-2020-322429.","journal-title":"Gut"},{"key":"839_CR176","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004;44:601\u20137.","journal-title":"Neuron"},{"key":"839_CR177","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Paisan-Ruiz","year":"2004","unstructured":"Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, Lopez de Munain A, Aparicio S, Gil AM, Khan N, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron. 2004;44:595\u2013600.","journal-title":"Neuron"},{"key":"839_CR178","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ng.175","volume":"40","author":"JC Barrett","year":"2008","unstructured":"Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn\u2019s disease. Nat Genet. 2008;40:955\u201362.","journal-title":"Nat Genet"},{"key":"839_CR179","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/cr.2012.42","volume":"22","author":"Z Liu","year":"2012","unstructured":"Liu Z, Lenardo MJ. The role of LRRK2 in inflammatory bowel disease. Cell Res. 2012;22:1092\u20134.","journal-title":"Cell Res"},{"key":"839_CR180","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.4049\/jimmunol.1000548","volume":"185","author":"A Gardet","year":"2010","unstructured":"Gardet A, Benita Y, Li C, Sands BE, Ballester I, Stevens C, Korzenik JR, Rioux JD, Daly MJ, Xavier RJ, Podolsky DK. LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol. 2010;185:5577\u201385.","journal-title":"J Immunol"},{"key":"839_CR181","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1126\/science.aar5683","volume":"360","author":"DR Alessi","year":"2018","unstructured":"Alessi DR, Sammler E. LRRK2 kinase in Parkinson\u2019s disease. Science. 2018;360:36\u20137.","journal-title":"Science"},{"key":"839_CR182","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1084\/jem.20170014","volume":"214","author":"W Liu","year":"2017","unstructured":"Liu W, Liu X, Li Y, Zhao J, Liu Z, Hu Z, Wang Y, Yao Y, Miller AW, Su B, et al. LRRK2 promotes the activation of NLRC4 inflammasome during Salmonella Typhimurium infection. J Exp Med. 2017;214:3051\u201366.","journal-title":"J Exp Med"},{"key":"839_CR183","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/ni.3233","volume":"16","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Pan Y, Yan R, Zeng B, Wang H, Zhang X, Li W, Wei H, Liu Z. Commensal bacteria direct selective cargo sorting to promote symbiosis. Nat Immunol. 2015;16:918\u201326.","journal-title":"Nat Immunol"},{"key":"839_CR184","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1093\/hmg\/ddu138","volume":"23","author":"J Schapansky","year":"2014","unstructured":"Schapansky J, Nardozzi JD, Felizia F, LaVoie MJ. Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy. Hum Mol Genet. 2014;23:4201\u201314.","journal-title":"Hum Mol Genet"},{"key":"839_CR185","doi-asserted-by":"publisher","first-page":"e21519","DOI":"10.1371\/journal.pone.0021519","volume":"6","author":"J Th\u00e9venet","year":"2011","unstructured":"Th\u00e9venet J, PesciniGobert R, Hooft van Huijsduijnen R, Wiessner C, Sagot YJ. Regulation of LRRK2 expression points to a functional role in human monocyte maturation. PLoS ONE. 2011;6:e21519.","journal-title":"PLoS ONE"},{"key":"839_CR186","doi-asserted-by":"publisher","first-page":"eaan8162","DOI":"10.1126\/scitranslmed.aan8162","volume":"10","author":"T Takagawa","year":"2018","unstructured":"Takagawa T, Kitani A, Fuss I, Levine B, Brant SR, Peter I, Tajima M, Nakamura S, Strober W. An increase in LRRK2 suppresses autophagy and enhances Dectin-1-induced immunity in a mouse model of colitis. Sci Transl Med. 2018;10:eaan8162.","journal-title":"Sci Transl Med"},{"key":"839_CR187","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/mds.28890","volume":"37","author":"CH Lin","year":"2022","unstructured":"Lin CH, Lin HY, Ho EP, Ke YC, Cheng MF, Shiue CY, Wu CH, Liao PH, Hsu AY, Chu LA, et al. Mild chronic colitis triggers Parkinsonism in LRRK2 mutant mice through activating TNF-alpha pathway. Mov Disord. 2022;37:745\u201357.","journal-title":"Mov Disord"},{"key":"839_CR188","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/mds.26529","volume":"31","author":"N Dzamko","year":"2016","unstructured":"Dzamko N, Rowe DB, Halliday GM. Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers. Mov Disord. 2016;31:889\u201397.","journal-title":"Mov Disord"},{"key":"839_CR189","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"XY Qin","year":"2016","unstructured":"Qin XY, Zhang SP, Cao C, Loh YP, Cheng Y. Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol. 2016;73:1316\u201324.","journal-title":"JAMA Neurol"},{"key":"839_CR190","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.4049\/jimmunol.1000548","volume":"185","author":"A Gardet","year":"2010","unstructured":"Gardet A, Benita Y, Li C, Sands BE, Ballester I, Stevens C, Korzenik JR, Rioux JD, Daly MJ, Xavier RJ, Podolsky DK. LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol (Baltimore, Md: 1950). 2010;185:5577\u201385.","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"839_CR191","doi-asserted-by":"publisher","first-page":"819373","DOI":"10.3389\/fnagi.2021.819373","volume":"13","author":"P-H Liao","year":"2022","unstructured":"Liao P-H, Chiang H-L, Shun C-T, Hang J-F, Chiu H-M, Wu M-S, Lin C-H. Colonic Leucine-Rich Repeat Kinase 2 expression is increased and associated with disease severity in patients with Parkinson\u2019s disease. Front Aging Neurosci. 2022;13:819373.","journal-title":"Front Aging Neurosci"},{"key":"839_CR192","doi-asserted-by":"publisher","first-page":"819373","DOI":"10.3389\/fnagi.2021.819373","volume":"13","author":"PH Liao","year":"2021","unstructured":"Liao PH, Chiang HL, Shun CT, Hang JF, Chiu HM, Wu MS, Lin CH. Colonic Leucine-Rich Repeat Kinase 2 expression is increased and associated with disease severity in patients with Parkinson\u2019s disease. Front Aging Neurosci. 2021;13:819373.","journal-title":"Front Aging Neurosci"},{"key":"839_CR193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong YC, Krainc D. \u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat Med. 2017;23:1\u201313.","journal-title":"Nat Med"},{"key":"839_CR194","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40035-019-0146-z","volume":"8","author":"L Rota","year":"2019","unstructured":"Rota L, Pellegrini C, Benvenuti L, Antonioli L, Fornai M, Blandizzi C, Cattaneo A, Colla E. Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy. Transl Neurodegener. 2019;8:5.","journal-title":"Transl Neurodegener"},{"key":"839_CR195","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.parkreldis.2018.10.028","volume":"61","author":"SJ Chung","year":"2019","unstructured":"Chung SJ, K\u00f6nig IR, Lohmann K, Hinrichs F, Kim J, Ryu HS, Lee HJ, Kim K, Lee JH, Jung KW, et al. Association of SNCA variants with \u03b1-synuclein of gastric and colonic mucosa in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2019;61:151\u20135.","journal-title":"Parkinsonism Relat Disord"},{"key":"839_CR196","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41531-021-00218-2","volume":"7","author":"ZD Wallen","year":"2021","unstructured":"Wallen ZD, Stone WJ, Factor SA, Molho E, Zabetian CP, Standaert DG, Payami H. Exploring human-genome gut-microbiome interaction in Parkinson\u2019s disease. NPJ Parkinson\u2019s Dis. 2021;7:74.","journal-title":"NPJ Parkinson's Dis"},{"key":"839_CR197","doi-asserted-by":"publisher","first-page":"531","DOI":"10.4161\/auto.7.5.14684","volume":"7","author":"MK McCoy","year":"2011","unstructured":"McCoy MK, Cookson MR. DJ-1 regulation of mitochondrial function and autophagy through oxidative stress. Autophagy. 2011;7:531\u20132.","journal-title":"Autophagy"},{"key":"839_CR198","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3233\/JPD-2011-11041","volume":"1","author":"M Oliveras-Salv\u00e1","year":"2011","unstructured":"Oliveras-Salv\u00e1 M, Van Rompuy AS, Heeman B, Van den Haute C, Baekelandt V. Loss-of-function rodent models for parkin and PINK1. J Parkinsons Dis. 2011;1:229\u201351.","journal-title":"J Parkinsons Dis"},{"key":"839_CR199","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cell.2016.05.039","volume":"166","author":"D Matheoud","year":"2016","unstructured":"Matheoud D, Sugiura A, Bellemare-Pelletier A, Laplante A, Rondeau C, Chemali M, Fazel A, Bergeron JJ, Trudeau L-E, Burelle Y, et al. Parkinson\u2019s disease-related proteins PINK1 and Parkin repress mitochondrial antigen presentation. Cell. 2016;166:314\u201327.","journal-title":"Cell"},{"key":"839_CR200","doi-asserted-by":"publisher","first-page":"16131","DOI":"10.1038\/s41598-020-72903-w","volume":"10","author":"Y Singh","year":"2020","unstructured":"Singh Y, Trautwein C, Dhariwal A, Salker MS, Alauddin M, Zizmare L, Pelzl L, Feger M, Admard J, Casadei N, et al. DJ-1 (Park7) affects the gut microbiome, metabolites and the development of innate lymphoid cells (ILCs). Sci Rep. 2020;10:16131.","journal-title":"Sci Rep"},{"key":"839_CR201","doi-asserted-by":"publisher","first-page":"e7551","DOI":"10.1371\/journal.pone.0007551","volume":"4","author":"KK Johansen","year":"2009","unstructured":"Johansen KK, Wang L, Aasly JO, White LR, Matson WR, Henchcliffe C, Beal MF, Bogdanov M. Metabolomic profiling in LRRK2-related Parkinson\u2019s disease. PLoS ONE. 2009;4:e7551.","journal-title":"PLoS ONE"},{"key":"839_CR202","doi-asserted-by":"publisher","first-page":"103908","DOI":"10.1016\/j.isci.2022.103908","volume":"25","author":"DP Amorim Neto","year":"2022","unstructured":"Amorim Neto DP, Bosque BP, Pereira de Godoy JV, Rodrigues PV, Meneses DD, Tostes K, Costa Tonoli CC, Faustino de Carvalho H, Gonz\u00e1lez-Billault C, de Castro Fonseca M. Akkermansia muciniphila induces mitochondrial calcium overload and a-synuclein aggregation in an enteroendocrine cell line. iScience. 2022;25:103908.","journal-title":"iScience"},{"key":"839_CR203","doi-asserted-by":"publisher","first-page":"147118","DOI":"10.1016\/j.brainres.2020.147118","volume":"1748","author":"B Toczylowska","year":"2020","unstructured":"Toczylowska B, Zieminska E, Micha\u0142owska M, Chalimoniuk M, Fiszer U. Changes in the metabolic profiles of the serum and putamen in Parkinson\u2019s disease patients\u2014in vitro and in vivo NMR spectroscopy studies. Brain Res. 2020;1748:147118.","journal-title":"Brain Res"},{"key":"839_CR204","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jchromb.2018.01.025","volume":"1081\u20131082","author":"H Zhao","year":"2018","unstructured":"Zhao H, Wang C, Zhao N, Li W, Yang Z, Liu X, Le W, Zhang X. Potential biomarkers of Parkinson\u2019s disease revealed by plasma metabolic profiling. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1081\u20131082:101\u20138.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-022-00839-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-022-00839-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-022-00839-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T04:59:48Z","timestamp":1659157188000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-022-00839-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":204,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1186\/s12929-022-00839-6","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,27]]},"assertion":[{"value":"13 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed by the Institutional Research Board Committee at National Taiwan University Hospital and carried out in accordance with relevant regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors report no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}